Enteroviruses (EVs) are a diverse group of viruses and a common cause of multiple infections in children. A recent Pediatric Investigation review examines EV infections, highlighting the challenges posed by viral diversity, rapid evolution, immune evasion, and limited treatment and vaccine options. Currently, no specific antiviral treatment exists for EV, and prevention is limited since current vaccines cover only certain serotypes, underscoring the need for further research to expand both preventive and therapeutic options.

NYU Langone Health has named William Gordon Frankle, MD, MBA, an established leader with a proven track record of success, as the new chair of the Department of Psychiatry at NYU Grossman School of Medicine.

A therapeutic approach pioneered in Mainz for the treatment of multiple sclerosis (MS) is taking an important step toward clinical application. The team led by Professor Claire Jacob at Johannes Gutenberg University Mainz (JGU) is further developing a drug patch that could promote the repair of damaged myelin sheaths. ForTra gGmbH for Research Transfer (ForTra), a subsidiary of the Else Kröner-Fresenius Foundation, is supporting the project with EUR 1.1 million. The aim is to further develop the patch for production according to pharmaceutical quality standards and subsequently assess its safety and tolerability in an initial clinical trial.